When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
MP3•Episode home
Manage episode 356030931 series 3448744
Content provided by NYU Langone Health Department of Psychiatry. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NYU Langone Health Department of Psychiatry or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dan Iosifescu, MD, is an Associate Professor of Psychiatry at the NYU Grossman School of Medicine and director of clinical research at the Nathan Kline Institute for Psychiatric Research. His research has led to the validation of novel treatments for patients with severe mood and anxiety disorders, including pharmacological treatments such as ketamine and other glutamatergic drugs, and devices such as novel forms of magnetic stimulation.
Topics covered:
- Ketamine and Esketamine
- Why certain people respond better to certain medications
- SSRI mechanism of action
- Transcranial magnetic stimulation
Visit our website for more Insights on Psychiatry.
Watch this episode on YouTube
Executive Producer: Jon Earle
33 episodes